Search Results - Markus Knuf

Refine Results
  1. 1
    The burden of seasonal and pandemic influenza in infants and children

    The burden of seasonal and pandemic influenza in infants and children by B. Ruf, Markus Knuf

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies

    The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies by Christopher S. Ambrose, Xionghua Wu, Markus Knuf, Peter Wutzler

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination

    Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination by Cynthia Burman, Markus Knuf, Marco Aurélio Palazzi Sáfadi, Jamie Findlow

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany

    4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany by Martin Eichner, Markus Schwehm, Johannes Hain, Helmut Uphoff, Bernd Salzberger, Markus Knuf, Ruprecht Schmidt‐Ott

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)

    Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) by Markus Knuf, Leszek Szenborn, Masnuel Moro, C. Petit, Nancy Bermal, Laurence Bernard, Ilse Dieussaert, Lode Schuerman

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine

    Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine by Fred Zepp, Markus Knuf, P. Habermehl, Joe Schmitt, C Rebsch, Peter Schmidtke, Ralf Clemens, M. Slaoui

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age

    Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age by Achim Fieß, Ruth Kölb‐Keerl, Alexander K. Schuster, Markus Knuf, Bernd Kirchhof, Philipp S. Muether, Jacqueline Bauer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Are Meteorological Parameters Associated with Acute Respiratory Tract Infections?

    Are Meteorological Parameters Associated with Acute Respiratory Tract Infections? by Jean‐Baptist du Prel, Wolfram Puppe, Britta Gröndahl, Markus Knuf, Josef Weigl, Franziska Schaaff, Heinz‐Josef Schmitt

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines

    Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccine... by Bertrand Chevallier, Timo Vesikari, Jerzy Brzostek, Markus Knuf, Nancy Bermal, Javier Arístegui, Dorota Borys, Jan Cleerbout, Patricia Lommel, Lode Schuerman

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

    Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Ser... by Jacek Wysocki, Juan Carlos Tejedor Torres, Dutlef Grunert, Ryszard Konior, José García-Sicilia, Markus Knuf, Laurence Bernard, Ilse Dieussaert, Lode Schuerman

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity

    Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vac... by Félix Omeñaca, Liliana Vázquez, Pilar Garcı́a-Corbeira, Narcisa Mesaros, Linda Hanssens, Jan Dolhain, Ivonne Puente Gómez, Johannes G. Liese, Markus Knuf

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

    Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children by Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger‐Baum, Heinz‐Josef Schmitt, Frank Baehner, Astrid Borkowski, Theodore F. Tsai, Ralf Clemens

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study

    The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study by Markus A. Rose, Oliver Damm, Wolfgang Greiner, Markus Knuf, Peter Wutzler, Johannes G. Liese, H. Krüger, U. Wahn, Tom Schaberg, Markus Schwehm, Thomas F Kochmann, Martin Eichner

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    HUMAN TOLL-LIKE RECEPTOR 4 MUTATIONS ARE ASSOCIATED WITH SUSCEPTIBILITY TO INVASIVE MENINGOCOCCAL DISEASE IN INFANCY

    HUMAN TOLL-LIKE RECEPTOR 4 MUTATIONS ARE ASSOCIATED WITH SUSCEPTIBILITY TO INVASIVE MENINGOCOCCAL DISEASE IN INFANCY by Joerg Faber, Claudius U. Meyer, Christina Gemmer, Alexandra Russo, Adam Finn, Craig Murdoch, Werner Zenz, Christine Mannhalter, Bernhard Zabel, Heinz J. Schmitt, Pirmin Habermehl, Fred Zepp, Markus Knuf

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia

    S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia by Gerd Gross, Lisa Eisert, Hans Wilhelm Doerr, Helmut Fickenscher, Markus Knuf, Philip Maier, Matthias Maschke, Rainer Müller, Uwe Pleyer, Michael Schäfer, Cord Sunderkötter, Ricardo Niklas Werner, Peter Wutzler, Alexander Nast

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    S2k‐Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie

    S2k‐Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie by Gerd Gross, Lisa Eisert, Hans Wilhelm Doerr, Helmut Fickenscher, Markus Knuf, Philip Maier, Matthias Maschke, Rainer Müller, Uwe Pleyer, Michael Schäfer, Cord Sunderkötter, Ricardo Niklas Werner, Peter Wutzler, Alexander Nast

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines

    Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines by Susanna Esposito, Paola Stefanelli, Norman K. Fry, Giorgio Fedele, Qiushui He, Pauline Paterson, Tina Q. Tan, Markus Knuf, Carlos Rodrigo, Catherine Olivier, Katie L. Flanagan, Ivan Fan‐Ngai Hung, Iria Lutsar, Kathryn M. Edwards, Miguel O’Ryan, Nicola Principi

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants by Simon B. Drysdale, Katrina Cathie, Florence Flamein, Markus Knuf, Andrea M. Collins, Helen Hill, Friedrich W. Kaiser, Jonathan Cohen, Didier Pinquier, Christian Felter, Natalya Vassilouthis, Jing Jin, Mathieu Bangert, Karine Mari, Rapi Nteene, Sophie Wagué, Michelle Roberts, Pierre Tissières, Simon Royal, Saul N. Faust

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial

    180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b... by Alasdair Munro, Simon B. Drysdale, Katrina Cathie, Florence Flamein, Markus Knuf, Andrea M. Collins, Helen Hill, Friedrich Kaiser, Jonathan Cohen, Didier Pinquier, Natalya Vassilouthis, M.N.P. Carreño, Catherine Moreau, Pierre Bourron, Lydie Marcelon, Karine Mari, Michelle Roberts, Pierre Tissières, Simon Royal, Saul N. Faust

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study

    A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort st... by Cihan Papan, Alberto Argentiero, Marian Porwoll, Ummaya Hakim, Edoardo Farinelli, Ilaria Testa, Maria Bruna Pasticci, Daniele Mezzetti, Katia Perruccio, Liat Etshtein, Niv Mastboim, Einat Moscoviz, Tahel Ilan Ber, Asi Cohen, Einav Simon, Olga Boico, Liran Shani, Tanya M. Gottlieb, Roy Navon, Eran Barash, Kfir Oved, Eran Eden, Arne Simon, Johannes G. Liese, Markus Knuf, Michal Stein, Renata Yacobov, Ellen Bamberger, Sven Schneider, Susanna Esposito, Tobias Tenenbaum

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: